CHKGF(CHKGF)
CHKGF
No analyst ratings available
No analyst price targets available for CHKGF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $66.03B | $55.40B | $62.82B | $85.50B |
| Low | $57.72B | $43.30B | $52.11B | $70.92B |
| High | $84.94B | $72.50B | $81.49B | $110.90B |
| EBITDA Avg | $20.22B | $19.42B | $21.72B | $25.56B |
| Low | $16.68B | $16.07B | $17.88B | $20.94B |
| High | $26.39B | $25.27B | $28.41B | $33.62B |
| EBIT Avg | $17.84B | $16.99B | $19.18B | $22.72B |
| Low | $14.29B | $13.64B | $15.34B | $18.09B |
| High | $24.01B | $22.84B | $25.87B | $30.77B |
| Net Income Avg | $13.60B | $12.88B | $14.74B | $17.75B |
| Low | $10.59B | $10.03B | $11.48B | $13.82B |
| High | $18.85B | $17.86B | $20.44B | $24.61B |
| EPS Avg | $3.89 | $3.68 | $4.21 | $5.07 |
| Low | $3.02 | $2.87 | $3.28 | $3.95 |
| High | $5.39 | $5.10 | $5.84 | $7.03 |
| Analysts (Rev / EPS) | 5 / 1 | 5 / 1 | 1 / 1 | 2 / 1 |